Literature DB >> 18940943

Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus.

Laura D Brown1, Paul J Rozance, James S Barry, Jacob E Friedman, William W Hay.   

Abstract

During late gestation, amino acids and insulin promote skeletal muscle protein synthesis. However, the independent effects of amino acids and insulin on the regulation of mRNA translation initiation in the fetus are relatively unknown. The purpose of this study was to determine whether acute amino acid infusion in the late-gestation ovine fetus, with and without a simultaneous increase in fetal insulin concentration, activates translation initiation pathway(s) in skeletal muscle. Fetuses received saline (C), mixed amino acid infusion plus somatostatin infusion to suppress amino acid-stimulated fetal insulin secretion (AA+S), mixed amino acid infusion with concomitant physiological increase in fetal insulin (AA), or high-dose insulin infusion with euglycemia and euaminoacidemia (HI). After a 2-h infusion period, fetal skeletal muscle was harvested under in vivo steady-state conditions and frozen for quantification of proteins both upstream and downstream of mammalian target of rapamycin (mTOR). In the AA group, we found a threefold increase in ribosomal protein S6 kinase (p70(S6k)) and Erk1/2 phosphorylation; however, blocking the physiological rise in insulin with somatostatin in the AA+S group prevented this increase. In the HI group, Akt, Erk1/2, p70(S6k), and ribosomal protein S6 were highly phosphorylated and 4E-binding protein 1 (4E-BP1) associated with eukaryotic initiation factor (eIF)4E decreased by 30%. These data show that insulin is a significant regulator of intermediates involved in translation initiation in ovine fetal skeletal muscle. Furthermore, the effect of amino acids is dependent on a concomitant increase in fetal insulin concentrations, because amino acid infusion upregulates p70(S6k) and Erk only when amino acid-stimulated increase in insulin occurs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940943      PMCID: PMC2636989          DOI: 10.1152/ajpendo.90310.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  48 in total

Review 1.  Amino acids and mTOR signalling in anabolic function.

Authors:  C G Proud
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

2.  Regulation of cardiac and skeletal muscle protein synthesis by individual branched-chain amino acids in neonatal pigs.

Authors:  Jeffery Escobar; Jason W Frank; Agus Suryawan; Hanh V Nguyen; Scot R Kimball; Leonard S Jefferson; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-08       Impact factor: 4.310

Review 3.  The mTOR pathway in the control of protein synthesis.

Authors:  Xuemin Wang; Christopher G Proud
Journal:  Physiology (Bethesda)       Date:  2006-10

4.  Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.

Authors:  Xuemin Wang; Anne Beugnet; Mirei Murakami; Shinya Yamanaka; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle.

Authors:  Daniel Cuthbertson; Kenneth Smith; John Babraj; Graham Leese; Tom Waddell; Philip Atherton; Henning Wackerhage; Peter M Taylor; Michael J Rennie
Journal:  FASEB J       Date:  2004-12-13       Impact factor: 5.191

6.  Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation.

Authors:  J C Anthony; T G Anthony; S R Kimball; T C Vary; L S Jefferson
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

7.  Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

Authors:  Li Ma; Zhenbang Chen; Hediye Erdjument-Bromage; Paul Tempst; Pier Paolo Pandolfi
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

8.  Effect of hyperinsulinemia on amino acid utilization and oxidation independent of glucose metabolism in the ovine fetus.

Authors:  Laura D Brown; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-07-25       Impact factor: 4.310

9.  Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated.

Authors:  Agus Suryawan; Renan A Orellana; Hanh V Nguyen; Asumthia S Jeyapalan; Jillian R Fleming; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-18       Impact factor: 4.310

10.  Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning.

Authors:  Sheng-Li Cai; Andrew R Tee; John D Short; Judith M Bergeron; Jinhee Kim; Jianjun Shen; Ruifeng Guo; Charles L Johnson; Kaoru Kiguchi; Cheryl Lyn Walker
Journal:  J Cell Biol       Date:  2006-04-24       Impact factor: 10.539

View more
  27 in total

1.  Prolonged infusion of amino acids increases leucine oxidation in fetal sheep.

Authors:  Anne M Maliszewski; Monika M Gadhia; Meghan C O'Meara; Stephanie R Thorn; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

2.  Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep.

Authors:  Laura D Brown; Paul J Rozance; Stephanie R Thorn; Jacob E Friedman; William W Hay
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

3.  Prolonged amino acid infusion into intrauterine growth-restricted fetal sheep increases leucine oxidation rates.

Authors:  Sandra G Wai; Paul J Rozance; Stephanie R Wesolowski; William W Hay; Laura D Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-09-11       Impact factor: 4.310

Review 4.  The impact of IUGR on pancreatic islet development and β-cell function.

Authors:  Brit H Boehmer; Sean W Limesand; Paul J Rozance
Journal:  J Endocrinol       Date:  2017-08-14       Impact factor: 4.286

5.  Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus.

Authors:  Sasha E Andrews; Laura D Brown; Stephanie R Thorn; Sean W Limesand; Melissa Davis; William W Hay; Paul J Rozance
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

6.  Skeletal muscle amino acid uptake is lower and alanine production is greater in late gestation intrauterine growth-restricted fetal sheep hindlimb.

Authors:  Eileen I Chang; Stephanie R Wesolowski; Elizabeth A Gilje; Peter R Baker; Julie A Reisz; Angelo D'Alessandro; William W Hay; Paul J Rozance; Laura D Brown
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

7.  Maternal obesity downregulates myogenesis and beta-catenin signaling in fetal skeletal muscle.

Authors:  Jun F Tong; Xu Yan; Mei J Zhu; Stephen P Ford; Peter W Nathanielsz; Min Du
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-01-27       Impact factor: 4.310

8.  Increased amino acid supply potentiates glucose-stimulated insulin secretion but does not increase β-cell mass in fetal sheep.

Authors:  Monika M Gadhia; Anne M Maliszewski; Meghan C O'Meara; Stephanie R Thorn; Jinny R Lavezzi; Sean W Limesand; William W Hay; Laura D Brown; Paul J Rozance
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

9.  Chronically Increased Amino Acids Improve Insulin Secretion, Pancreatic Vascularity, and Islet Size in Growth-Restricted Fetal Sheep.

Authors:  Laura D Brown; Melissa Davis; Sandra Wai; Stephanie R Wesolowski; William W Hay; Sean W Limesand; Paul J Rozance
Journal:  Endocrinology       Date:  2016-08-08       Impact factor: 4.736

Review 10.  Impact of placental insufficiency on fetal skeletal muscle growth.

Authors:  Laura D Brown; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2016-03-16       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.